Research map: Clinical outcomes after switching from mepolizumab to benralizumab in eosinophilic granulomatosis with polyangiitis: A single-centre retrospective cohort study

Back to the article

Papers in this map

  1. Modification and validation of the Birmingham Vasculitis Activity Score (version 3) · Chetan B. Mukhtyar · 2008 · 1253 citations · Cited by this paper
  2. Clinical performance of three anti-dsDNA antibody immunoassays in systemic lupus erythematosus · 2026 · Related
  3. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis · Michael E. Wechsler · 2017 · 1094 citations · Cited by this paper
  4. Autoantibodies against adenosine deaminase acting on RNA1 in patients with systemic lupus erythematosus: Its relationship to clinical features and other autoantibodies · 2026 · Related
  5. The Five-Factor Score Revisited · Loı̈c Guillevin · 2010 · 956 citations · Cited by this paper
  6. Treatment outcomes of periprosthetic fracture following unlinked total elbow arthroplasty: A case series study · 2026 · Related
  7. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update · Bernhard Hellmich · 2023 · 753 citations · Cited by this paper
  8. Efficacy and safety of canakinumab in patients with adult-onset Still’s disease: Results from an open-label phase III study in Japan · 2026 · Related
  9. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis · Peter C. Grayson · 2022 · 560 citations · Cited by this paper
  10. Disentangling temporal factors in organ damage accrual in systemic lupus erythematosus: Onset-age, onset-era, and ageing in the Japanese LUNA registry · 2026 · Related
  11. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis · Michael E. Wechsler · 2024 · 223 citations · Cited by this paper
  12. Inebilizumab treatment in Japanese patients with IgG4-related disease: A subgroup analysis of a randomized, double-blind, placebo-controlled, phase 3 trial (MITIGATE) · 2026 · Related
  13. Eosinophilic Granulomatosis with Polyangiitis: An Overview · Andrea Gioffredi · 2014 · 218 citations · Cited by this paper
  14. Prevalence of and factors associated with radiographic sacroiliitis in Japanese patients with inflammatory bowel disease: A computed tomography–based study · 2026 · Related
  15. Eosinophilic granulomatosis with polyangiitis – Advances in pathogenesis, diagnosis, and treatment · Justyna Fijołek · 2023 · 91 citations · Cited by this paper
  16. Effectiveness and safety of sarilumab in polymyalgia rheumatica: A retrospective study of the FIRST registry · 2026 · Related
  17. Benralizumab for eosinophilic granulomatosis with polyangiitis · Adrien Cottu · 2023 · 50 citations · Cited by this paper
  18. Impact of anti-drug antibodies and neutralising antibodies on safety and efficacy of ozoralizumab in rheumatoid arthritis · 2026 · Related
  19. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study · Alessandra Bettiol · 2023 · 35 citations · Cited by this paper
  20. Assessment of residual symptoms using the Okomarigoto Sheet can complement evaluation of the patient acceptable symptom state in patients with rheumatoid arthritis · 2026 · Related
  21. Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma · Michael Fricker · 2024 · 26 citations · Cited by this paper
  22. Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis · Peter A. Merkel · 2025 · 22 citations · Cited by this paper
  23. Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies · Mayu Shiomi · 2025 · 19 citations · Cited by this paper
  24. Single-centre, cross-sectional study on the factors and reasons for non-vaccination among patients with rheumatoid arthritis · Hirofumi Miyake · 2023 · 9 citations · Cited by this paper
  25. Factors and Reasons for Non-vaccination among Patients with Systemic Lupus Erythematosus: A Single-centre, Cross-sectional Study · Hirofumi Miyake · 2022 · 7 citations · Cited by this paper
  26. Systematic Literature Review of Real-World Outcomes of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis · David J. Jackson · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)